MedPath

TALVEY

TALVEY

Approved
DIN Number

02547406

Drug Class

Human

Market Date

Mar 4, 2025

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02547406
AIG Number0165883002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01FX29 TALQUETAMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TALQUETAMABActive
Strength: 40 MG / ML
Monograph: TALQUETAMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.